Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Cord Blood Lands $50 Million from Golden Meditech

publication date: Sep 18, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China Cord Blood Corp. announced that its corporate parent, Golden Meditech Holdings, would invest another $50 million in China Cord Blood, allowing it to expand its business – perhaps beyond China. Golden Meditech already owns 42% of CCBC. The new investment is a convertible bond that can be converted into another 15.5% of the company. CCBC seems to already have a lot of cash.  More details....

Stock Symbols: (NYSE: CO) (HK: 801; TW: 910801)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

Bio Taiwan 2015
July 22-26, 2015
Taipei, Taiwan


BioPharm America™ 2015
September 15–17, 2015
Boston, USA

>> More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors